Secugen S.L.

Secugen S.L. is a biotechnology startup based in Spain that specializes in Automatic DNA Sequencing and Genetic Diagnostic services. The company offers advanced technologies in the sequencing and DNA genotyping field, providing technical assistance and monitoring to inexperienced customers. Secugen's services cater to more than 800 customers, including universities, research centers, hospitals, and companies.

Moreover, Secugen is actively involved in the genetic diagnostic of rare diseases, collaborating with physicians from over 150 hospitals and health centers. Their services encompass a wide range of pathologies, from Alzheimer's to rare diseases such as atypical Hemolytic Uremic Syndrome.

In addition to its service offerings, Secugen is engaged in R & D activities, developing research projects financed with own funds or grants from public agencies. The company focuses on improving and optimizing processes and developing specific developments in major diseases.

Established in 2005, Secugen represents an innovative force in the biotechnology sector, offering essential services in the realm of genetic research and diagnostics. As of now, there is no public information available about recent investments or investors associated with Secugen S.L.